These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Levels of immunoglobulin A1 and messenger RNA for interferon gamma and tumor necrosis factor alpha in total saliva from patients with diabetes mellitus type 2 with chronic periodontal disease. Gomes MA; Rodrigues FH; Afonso-Cardoso SR; Buso AM; Silva AG; Favoreto S; Souza MA J Periodontal Res; 2006 Jun; 41(3):177-83. PubMed ID: 16677285 [TBL] [Abstract][Full Text] [Related]
5. Periodontal disease: an overview for physicians. Fenesy KE Mt Sinai J Med; 1998; 65(5-6):362-9. PubMed ID: 9844364 [TBL] [Abstract][Full Text] [Related]
6. Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-alpha in a 2-way relationship. Nishimura F; Iwamoto Y; Mineshiba J; Shimizu A; Soga Y; Murayama Y J Periodontol; 2003 Jan; 74(1):97-102. PubMed ID: 12593603 [TBL] [Abstract][Full Text] [Related]
7. Effects of diabetes mellitus on periodontal and peri-implant conditions: update on associations and risks. Salvi GE; Carollo-Bittel B; Lang NP J Clin Periodontol; 2008 Sep; 35(8 Suppl):398-409. PubMed ID: 18724865 [TBL] [Abstract][Full Text] [Related]
8. The effect of systemic anti-tumor necrosis factor-alpha treatment on Porphyromonas gingivalis infection in type 2 diabetic mice. Takano M; Nishihara R; Sugano N; Matsumoto K; Yamada Y; Takane M; Fujisaki Y; Ito K Arch Oral Biol; 2010 May; 55(5):379-84. PubMed ID: 20381011 [TBL] [Abstract][Full Text] [Related]
9. Periodontitis and diabetes interrelationships: role of inflammation. Iacopino AM Ann Periodontol; 2001 Dec; 6(1):125-37. PubMed ID: 11887455 [TBL] [Abstract][Full Text] [Related]
10. Ex vivo lipopolysaccharide (LPS)-induced TNF-alpha, IL-1beta, IL-6 and PGE2 secretion in whole blood from Type 1 diabetes mellitus patients with or without aggressive periodontitis. Araya AV; Pavez V; Perez C; Gonzalez F; Columbo A; Aguirre A; Schiattino I; Aguillón JC Eur Cytokine Netw; 2003; 14(3):128-33. PubMed ID: 14656685 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757 [TBL] [Abstract][Full Text] [Related]
12. Autoimmune diabetes in adults: lessons from the UKPDS. Desai M; Clark A Diabet Med; 2008 Aug; 25 Suppl 2():30-4. PubMed ID: 18717976 [TBL] [Abstract][Full Text] [Related]
13. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus. Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000 [TBL] [Abstract][Full Text] [Related]
14. Frequency of pancreatic beta-cell autoimmunity markers in patients with autoimmune thyroid disease. Primo ME; Niepomniszcze H; Poskus E; Sala MS; Guaita SS; Sica MP; Villalba A; Cardoso A; Bruno OD Medicina (B Aires); 2008; 68(1):37-42. PubMed ID: 18416318 [TBL] [Abstract][Full Text] [Related]
15. Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients. Chiu HK; Tsai EC; Juneja R; Stoever J; Brooks-Worrell B; Goel A; Palmer JP Diabetes Res Clin Pract; 2007 Aug; 77(2):237-44. PubMed ID: 17234296 [TBL] [Abstract][Full Text] [Related]
16. "Diabetes and gum disease: the diabolic duo". Kumar M; Mishra L; Mohanty R; Nayak R Diabetes Metab Syndr; 2014; 8(4):255-8. PubMed ID: 25450824 [TBL] [Abstract][Full Text] [Related]